ArticleArchives of medical science : AMS2019
Risk factors for ischemic stroke in patients with non-valvular atrial fibrillation and therapeutic international normalized ratio range.
Article in Archives of medical science : AMS, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Improvement in age- and sex-dependent mortality in patients with atrial fibrillation between 2011 and 2016 - a nationwide retrospective study from Hungary.Archives of medical science : AMS · 2026Article
- Construction and validation of a regularized logistic regression model for predicting late recurrence after ablation in persistent atrial fibrillation: a clinical parameter approach.Frontiers in cardiovascular medicine · 2025Article
- Efficacy and safety of apixaban and warfarin in prevention of ischemic stroke: a systematic review and meta-analysis.Archives of medical science : AMS · 2025Review
- Discriminating factors excluding patients from a catheter-based left atrial appendage closure and an outcome analysis of non-intervened and intervened patients.Archives of medical science : AMS · 2024Article
- Limitations in Contemporary Pharmacological Stroke Prevention Therapies in Atrial Fibrillation: A Descriptive Literature Review.Journal of clinical medicine · 2023Review
- Evaluation of Blood Biomarkers and Parameters for the Prediction of Stroke Survivors' Functional Outcome upon Discharge Utilizing Explainable Machine Learning.Diagnostics (Basel, Switzerland) · 2023Article
- The emerging role of ferroptosis in myocardial fibrosis of atrial fibrillation.Archives of medical science : AMS · 2023Article
- Prothrombin Time-International Normalized Ratio Predicts the Outcome of Atrial Fibrillation Patients Taking Rivaroxaban.Biomedicines · 2022Article
- Admission Severity of Atrial-Fibrillation-Related Acute Ischemic Stroke in Patients under Anticoagulation Treatment: A Systematic Review and Meta-Analysis.Journal of clinical medicine · 2022Review
- Left Atrial Strain Helps Identifying the Cardioembolic Risk in Transient Ischemic Attacks Patients with Silent Paroxysmal Atrial Fibrillation.Therapeutics and clinical risk management · 2022Article
- Pre-Stroke Statin Therapy Improves In-Hospital Prognosis Following Acute Ischemic Stroke Associated with Well-Controlled Nonvalvular Atrial Fibrillation.Journal of clinical medicine · 2021Article
- The Effect of Transcranial Direct Current Stimulation and Functional Electrical Stimulation on the Lower Limb Function of Stroke Patients.Frontiers in neuroscience · 2021Article
- Cerebrovascular accidents differ between patients with atrial flutter and patients with atrial fibrillation.Archives of medical science : AMS · 2021Article
- Atrial fibrillation risk factors in patients with ischemic stroke.Archives of medical science : AMS · 2021Article
- Role of the interleukin-17 pathway in the pathogenesis of atrial fibrillation associated with inflammation.Archives of medical science : AMS · 2021Article
- LDL-C/HDL-C is associated with ischaemic stroke in patients with non-valvular atrial fibrillation: a case-control study.Lipids in health and disease · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionAtrial fibrillation (AF) is the most common cause of ischemic stroke (IS). Atrial fibrillation patients are recommended to use oral anticoagulants (OACs) as part of prevention against IS. However, despite having a therapeutic intensity of OAC therapy, IS can still occur in such patients. The aim of our study was to examine the configuration of IS risk factors in patients with non-valvular atrial fibrillation (NVAF) and within the therapeutic INR range (TINR). MATERIAL AND
methodsOur retrospective study involved 1835 patients with a recent IS. The experimental group consisted of 154 patients with acute IS, NVAF and TINR. The control group consisted of 1681 patients with acute IS but without AF.
resultsPatients with IS, NVAF and TINR were significantly older and more often female than patients with IS without NVAF (
conclusionsThe group of patients with NVAF and TINR is significantly more burdened by other independent common risk factors for stroke.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.